ABOUT VHIO

VHIO is a leading comprehensive cancer center of excellence where its scientists and physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer:

DISCOVER MORE

PROGRAMS & GROUPS

Scientific activity at VHIO is structured across for major programs: Preclinical, Translational, Clinical Research, and Core Technologies. Each incorporates research teams of excellence dedicated to harnessing and rapidly translating discoveries into tangible benefits for patients.

MEET VHIO´S TEAMS

NEWS

Re-evaluating splicing profiles and the pathogenicity of variants towards improved genetic diagnosis

12/09/2018|Comments Off on Re-evaluating splicing profiles and the pathogenicity of variants towards improved genetic diagnosis

Prostate Cancer Foundation announces VHIO’s Raquel Perez-Lopez as one of the recipients of its 2018 PCF Young Investigator Awards

28/08/2018|Comments Off on Prostate Cancer Foundation announces VHIO’s Raquel Perez-Lopez as one of the recipients of its 2018 PCF Young Investigator Awards

Old protein, new tricks: HMGA1 as a novel target for triple-negative breast cancer and predictor of metastatic cell spread

28/08/2018|Comments Off on Old protein, new tricks: HMGA1 as a novel target for triple-negative breast cancer and predictor of metastatic cell spread

New ESMO tumour DNA scale helps match patients with cancer to optimal targeted medicines

21/08/2018|Comments Off on New ESMO tumour DNA scale helps match patients with cancer to optimal targeted medicines

See all news

DIRECTION &
PRINCIPAL INVESTIGATORS

Research at VHIO is led by our Director, Josep Tabernero, and supported by a consultative body, VHIO´s Scientific Committee headed by José Baselga. A total of 25 renowned Principal Investigators manage and run VHIO´s major research themes and programs.

BROWSE OUR PIs
Launch our Scientific Report 2016

CLINICAL TRIALS

Driving drug development & targeted therapies against cancer, VHIO has become a leading reference in drug discovery from concept to clinic:

CLINICAL TRIALS OFFICE
RESEARCH UNIT FOR MOLECULAR THERAPY OF CANCER – “LA CAIXA”
CURRENTLY OPEN TRIALS

PROJECTS

Research at VHIO is made possible through the support received from private institutions, funding entities, companies and individuals, as well as International and National Competitive Grants. Find out more about our supporters, current projects and VHIO´s Scientific Coordination Area:

CURRENT PROJECTS
SCIENTIFIC COORDINATION

EVENTS

VHIO organizes symposia of excellence and ad-hoc courses & workshops through which it shares its expertise and promotes debate and exchange of the highest degree:

INTERNATIONAL SYMPOSIA
WORKSHOPS & COURSES
BENCHSTORMING SEMINARS